Original studyLife expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973–1983)☆
References (40)
Chagasic myocardiopathy
Prog Cardiovasc Dis
(1964)- et al.
Left ventricular cineangiography in Chagas' disease: detection of early myocardial damage
Am Heart J
(1982) - et al.
Right ventricular function in Chagas' disease
Int J Cardiol
(1983) - et al.
Electrocardiographic changes evoked by ajmaline in chronic Chagas' disease without manifest myocarditis
Am J Cardiol
(1982) - et al.
Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease
Am J Cardiol
(1983) - et al.
Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in Northeast Brazil
Am Heart J
(1983) - et al.
Do radically dissimilar Trypanosoma cruzi strains (zymodenes) cause Venezuelan and Brasilian forms of Chagas' disease?
Lancet
(1981) - et al.
The natural history of idiopathic dilated cardiomyopathy
Am J Cardiol
(1981) - et al.
Ten years of experience with amiodarone
Am Heart J
(1983)
Nova entidad morbida do homen: resumo general dos estudos etiologicos e clinocos
Mem Inst Oswaldo Cruz
Chagas' disease. A clinical, epidemiologic and pathologic study
Circulation
Mortality in Chagas' disease: life-table for the period 1949–1967 in an unselected population
Rev Inst Méd Trop São Paulo
Cuatro años de estudio longitudinal de una comunidad rural con endemicidad chagásica
Bol Of Sanit Panam
La dinámica epidemiológica de la enfermedad de Chagas en El Valle de los Naranjos. Estado Carabobo-Venezuela
Arch Ven Med Trop Parasitol Med
Contribución al estudio de la patología de la miocarditis chagásica en Venezuela
Arch Hosp Vargas
Aspectos clínicos de la enfermedad de Chagas: diagnóstico de daño miocardico
Interciencia
Diagnóstico por métodos no invasivos de daño ventricular izquierdo incipiente en pacientes chagásicos. Utilidad de la ecocardiografía y la fonomecanocardiografía
Arch Inst Cardiol Mex
La prueba de esfuerzo en la miocardiopatía chagásica crónica. Su valor en el diagnóstico precoz
Arq Bras Cardiol
Estudio de la función del nodo sinusal y de la conducción atrioventricular en pacientes con enfermedad de Chagas
Arch Inst Cardiol Mex
Cited by (96)
Trypanosomiasis
2022, Greene's Infectious Diseases of the Dog and Cat, Fifth EditionAge-related anomalies of electrocardiograms in patients from areas with differential Seroprevalence of Chagas disease in Southern Bolivia
2021, Parasite Epidemiology and ControlChronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment
2017, Journal of the American College of CardiologyThe role of CCR5 in Chagas disease - a systematic review
2016, Infection, Genetics and EvolutionGlobal economic burden of Chagas disease: A computational simulation model
2013, The Lancet Infectious DiseasesCitation Excerpt :Estimates generated by the model were much the same as those currently in the scientific literature in many ways. When individuals who entered the model were assumed to be 30 years of age (similar to 37·5 years [SD 13] reported by Espinosa and colleagues22 as the average age of those with indeterminate disease), onset of cardiomyopathy occurred at 52 years (11) and congestive heart failure at 60 years (12), which is much the same as the 52 years (14) for cardiomyopathy and 55 years (11) for congestive heart failure identified by Espinosa and colleagues and in an additional study in which the age of patients with cardiomyopathy ranged from 49 to 85 years.23 In our model, average duration of disease for those with cardiomyopathy was 11·6 years (10) and for those with congestive heart failure was 13·2 years (7·5), which is shorter than some other estimates (eg, 20–30 years for cardiomyopathy and 10–20 years for congestive heart failure23).
- ☆
Supported by grant No M-226 from the “Consejo de Desarrollo Científico y Humanistico de la Universidad de Los Andes”, Mérida, Venezuela.